 Nichole Carlson
Concepts (510)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bayes Theorem | 6 | 2020 | 350 | 1.420 |
Why?
| | Luteinizing Hormone | 11 | 2020 | 181 | 1.220 |
Why?
| | Models, Statistical | 6 | 2020 | 676 | 1.100 |
Why?
| | Hydrocortisone | 6 | 2015 | 333 | 0.990 |
Why?
| | Hormones | 3 | 2017 | 138 | 0.940 |
Why?
| | Emphysema | 1 | 2023 | 138 | 0.860 |
Why?
| | Hypothalamo-Hypophyseal System | 7 | 2017 | 220 | 0.790 |
Why?
| | Outpatients | 6 | 2023 | 335 | 0.790 |
Why?
| | Data Interpretation, Statistical | 3 | 2017 | 343 | 0.750 |
Why?
| | Diabetes Complications | 1 | 2022 | 222 | 0.740 |
Why?
| | Pulmonary Emphysema | 1 | 2023 | 365 | 0.730 |
Why?
| | Sarcoidosis, Pulmonary | 1 | 2019 | 58 | 0.700 |
Why?
| | Metadata | 1 | 2018 | 21 | 0.690 |
Why?
| | Radiography, Thoracic | 1 | 2019 | 172 | 0.670 |
Why?
| | State Health Plans | 2 | 2008 | 31 | 0.650 |
Why?
| | Computer Simulation | 4 | 2017 | 958 | 0.630 |
Why?
| | Follicle Stimulating Hormone | 9 | 2023 | 220 | 0.630 |
Why?
| | Ovary | 3 | 2017 | 213 | 0.610 |
Why?
| | Models, Biological | 3 | 2017 | 1772 | 0.590 |
Why?
| | Adrenocorticotropic Hormone | 2 | 2015 | 158 | 0.580 |
Why?
| | Reproduction | 1 | 2017 | 197 | 0.570 |
Why?
| | Genome | 1 | 2018 | 287 | 0.570 |
Why?
| | Residence Characteristics | 6 | 2010 | 315 | 0.570 |
Why?
| | Child Health Services | 2 | 2008 | 180 | 0.540 |
Why?
| | Contraceptives, Oral, Combined | 7 | 2011 | 16 | 0.530 |
Why?
| | Tomography, X-Ray Computed | 3 | 2019 | 2519 | 0.520 |
Why?
| | Software | 2 | 2019 | 653 | 0.510 |
Why?
| | Biometry | 2 | 2017 | 67 | 0.510 |
Why?
| | Health Services for the Aged | 2 | 2019 | 77 | 0.500 |
Why?
| | Obesity | 12 | 2023 | 2802 | 0.490 |
Why?
| | Brain Injuries | 5 | 2010 | 506 | 0.490 |
Why?
| | Computational Biology | 1 | 2018 | 661 | 0.490 |
Why?
| | Health Services Accessibility | 4 | 2010 | 816 | 0.480 |
Why?
| | Antiparkinson Agents | 3 | 2009 | 28 | 0.480 |
Why?
| | Pulsatile Flow | 1 | 2013 | 53 | 0.470 |
Why?
| | Environment Design | 3 | 2010 | 22 | 0.470 |
Why?
| | Circadian Rhythm | 4 | 2013 | 454 | 0.470 |
Why?
| | Humans | 87 | 2023 | 121869 | 0.460 |
Why?
| | Dehydroepiandrosterone | 1 | 2013 | 55 | 0.450 |
Why?
| | Specimen Handling | 1 | 2013 | 170 | 0.420 |
Why?
| | Gonadotropins | 3 | 2023 | 33 | 0.410 |
Why?
| | Saliva | 1 | 2013 | 228 | 0.410 |
Why?
| | Female | 67 | 2023 | 63903 | 0.410 |
Why?
| | Walking | 4 | 2010 | 434 | 0.400 |
Why?
| | Parkinson Disease | 4 | 2009 | 329 | 0.400 |
Why?
| | Alzheimer Disease | 4 | 2023 | 509 | 0.400 |
Why?
| | Adult | 47 | 2023 | 32683 | 0.390 |
Why?
| | Levodopa | 2 | 2007 | 24 | 0.380 |
Why?
| | Hypogonadism | 2 | 2015 | 79 | 0.370 |
Why?
| | White Matter | 2 | 2023 | 128 | 0.370 |
Why?
| | Oregon | 8 | 2011 | 72 | 0.370 |
Why?
| | Activities of Daily Living | 3 | 2010 | 378 | 0.370 |
Why?
| | Aged | 24 | 2023 | 20705 | 0.360 |
Why?
| | Endocrine System | 1 | 2009 | 23 | 0.360 |
Why?
| | Testosterone | 2 | 2010 | 371 | 0.350 |
Why?
| | Technology | 1 | 2009 | 89 | 0.330 |
Why?
| | Prenatal Care | 1 | 2010 | 251 | 0.330 |
Why?
| | Estradiol | 6 | 2023 | 485 | 0.330 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2167 | 0.330 |
Why?
| | Levonorgestrel | 4 | 2011 | 29 | 0.320 |
Why?
| | Cerebral Ventricles | 1 | 2007 | 51 | 0.320 |
Why?
| | Metrorrhagia | 3 | 2011 | 5 | 0.310 |
Why?
| | Health Behavior | 3 | 2010 | 745 | 0.310 |
Why?
| | Perception | 2 | 2007 | 317 | 0.310 |
Why?
| | Methylphenidate | 1 | 2007 | 37 | 0.300 |
Why?
| | Smoking Cessation | 1 | 2010 | 370 | 0.300 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2007 | 53 | 0.300 |
Why?
| | Young Adult | 14 | 2022 | 11223 | 0.290 |
Why?
| | Cognition Disorders | 3 | 2008 | 592 | 0.290 |
Why?
| | Male | 39 | 2022 | 60475 | 0.290 |
Why?
| | Middle Aged | 32 | 2021 | 28961 | 0.280 |
Why?
| | Aged, 80 and over | 11 | 2021 | 6974 | 0.280 |
Why?
| | Antibodies, Viral | 4 | 2023 | 579 | 0.270 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2022 | 3347 | 0.270 |
Why?
| | Longitudinal Studies | 10 | 2020 | 2652 | 0.270 |
Why?
| | Poverty | 2 | 2010 | 475 | 0.260 |
Why?
| | Time Factors | 13 | 2017 | 6889 | 0.260 |
Why?
| | Healthcare Disparities | 1 | 2010 | 492 | 0.260 |
Why?
| | Gliosis | 2 | 2023 | 37 | 0.260 |
Why?
| | Cluster Analysis | 2 | 2023 | 512 | 0.260 |
Why?
| | Medicaid | 1 | 2008 | 409 | 0.240 |
Why?
| | Lung | 3 | 2023 | 3767 | 0.240 |
Why?
| | Body Mass Index | 6 | 2019 | 2174 | 0.230 |
Why?
| | Oocytes | 2 | 2020 | 199 | 0.220 |
Why?
| | Socioeconomic Factors | 5 | 2010 | 1180 | 0.220 |
Why?
| | Cross-Sectional Studies | 12 | 2018 | 4713 | 0.220 |
Why?
| | Prospective Studies | 9 | 2023 | 6629 | 0.220 |
Why?
| | Benchmarking | 1 | 2023 | 180 | 0.210 |
Why?
| | Aging | 4 | 2008 | 1692 | 0.210 |
Why?
| | Hospitalization | 6 | 2022 | 1873 | 0.210 |
Why?
| | Markov Chains | 3 | 2017 | 124 | 0.210 |
Why?
| | Monte Carlo Method | 3 | 2017 | 150 | 0.210 |
Why?
| | Disability Evaluation | 4 | 2018 | 287 | 0.200 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2022 | 73 | 0.200 |
Why?
| | Healthy Aging | 1 | 2021 | 21 | 0.200 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2021 | 85 | 0.200 |
Why?
| | Doxycycline | 2 | 2011 | 63 | 0.200 |
Why?
| | Ethinyl Estradiol | 2 | 2011 | 17 | 0.200 |
Why?
| | Oocyte Donation | 1 | 2020 | 5 | 0.200 |
Why?
| | Preimplantation Diagnosis | 1 | 2020 | 4 | 0.200 |
Why?
| | Weight Gain | 2 | 2022 | 520 | 0.200 |
Why?
| | Memory, Episodic | 1 | 2021 | 45 | 0.190 |
Why?
| | Sarcoidosis | 1 | 2022 | 129 | 0.190 |
Why?
| | Prescription Drugs | 1 | 2022 | 113 | 0.190 |
Why?
| | Reproductive Techniques, Assisted | 1 | 2020 | 34 | 0.190 |
Why?
| | Cytomegalovirus Infections | 1 | 2022 | 182 | 0.190 |
Why?
| | Apomorphine | 3 | 2009 | 9 | 0.190 |
Why?
| | Menstruation | 2 | 1991 | 35 | 0.190 |
Why?
| | Fractals | 1 | 2019 | 6 | 0.180 |
Why?
| | Aromatase Inhibitors | 1 | 2020 | 52 | 0.180 |
Why?
| | Comprehensive Health Care | 1 | 2019 | 21 | 0.180 |
Why?
| | Radial Nerve | 1 | 1999 | 11 | 0.180 |
Why?
| | Quality of Life | 5 | 2018 | 2453 | 0.180 |
Why?
| | Nerve Compression Syndromes | 1 | 1999 | 30 | 0.180 |
Why?
| | Human Growth Hormone | 2 | 2014 | 40 | 0.180 |
Why?
| | Astrocytes | 1 | 2021 | 175 | 0.180 |
Why?
| | Health Status | 3 | 2010 | 797 | 0.170 |
Why?
| | Internet | 2 | 2018 | 698 | 0.170 |
Why?
| | Vital Capacity | 1 | 2019 | 287 | 0.170 |
Why?
| | Spirometry | 1 | 2019 | 319 | 0.170 |
Why?
| | Hip Fractures | 1 | 2019 | 82 | 0.170 |
Why?
| | Proportional Hazards Models | 3 | 2017 | 1190 | 0.170 |
Why?
| | Datasets as Topic | 1 | 2018 | 109 | 0.170 |
Why?
| | Contraception | 2 | 1991 | 127 | 0.160 |
Why?
| | Sheep, Domestic | 1 | 2017 | 30 | 0.160 |
Why?
| | Bibliometrics | 1 | 2018 | 67 | 0.160 |
Why?
| | Eligibility Determination | 2 | 2008 | 54 | 0.160 |
Why?
| | Rhinitis | 2 | 2010 | 116 | 0.160 |
Why?
| | Regression Analysis | 2 | 2019 | 1049 | 0.160 |
Why?
| | Reproductive Physiological Phenomena | 1 | 2017 | 1 | 0.160 |
Why?
| | Respiratory Function Tests | 1 | 2019 | 589 | 0.160 |
Why?
| | Risk Factors | 9 | 2022 | 9419 | 0.160 |
Why?
| | Algorithms | 3 | 2017 | 1618 | 0.150 |
Why?
| | Pregnancy | 8 | 2023 | 5663 | 0.150 |
Why?
| | Premature Birth | 1 | 2020 | 280 | 0.150 |
Why?
| | Medically Uninsured | 2 | 2008 | 132 | 0.150 |
Why?
| | Metabolic Diseases | 1 | 2018 | 106 | 0.150 |
Why?
| | Sinusitis | 2 | 2010 | 163 | 0.150 |
Why?
| | Family Planning Services | 2 | 2008 | 74 | 0.150 |
Why?
| | Double-Blind Method | 7 | 2011 | 1720 | 0.150 |
Why?
| | Lactation | 1 | 2018 | 179 | 0.150 |
Why?
| | Hypothyroidism | 2 | 2007 | 69 | 0.150 |
Why?
| | Affect | 3 | 2008 | 264 | 0.150 |
Why?
| | Proton Pump Inhibitors | 1 | 2017 | 102 | 0.150 |
Why?
| | Psychomotor Performance | 3 | 2009 | 335 | 0.150 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 231 | 0.150 |
Why?
| | Endoscopy | 2 | 2010 | 265 | 0.150 |
Why?
| | Low Back Pain | 1 | 2018 | 98 | 0.150 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2018 | 147 | 0.150 |
Why?
| | Retrospective Studies | 10 | 2023 | 13063 | 0.140 |
Why?
| | Cohort Studies | 5 | 2010 | 5300 | 0.140 |
Why?
| | Adolescent | 13 | 2020 | 19126 | 0.140 |
Why?
| | Immunologic Memory | 1 | 2018 | 323 | 0.140 |
Why?
| | Reproducibility of Results | 2 | 2017 | 2999 | 0.140 |
Why?
| | Antibodies | 1 | 2018 | 400 | 0.140 |
Why?
| | Models, Animal | 1 | 2017 | 373 | 0.140 |
Why?
| | Personnel Selection | 1 | 2016 | 75 | 0.140 |
Why?
| | Cross-Over Studies | 5 | 2009 | 474 | 0.140 |
Why?
| | Dietary Fats | 1 | 2018 | 339 | 0.140 |
Why?
| | Recovery of Function | 2 | 2010 | 612 | 0.140 |
Why?
| | Otolaryngology | 1 | 2016 | 82 | 0.130 |
Why?
| | Pulmonary Embolism | 1 | 2017 | 180 | 0.130 |
Why?
| | Patient Dropouts | 1 | 2015 | 75 | 0.130 |
Why?
| | Brain | 5 | 2023 | 2693 | 0.130 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2015 | 113 | 0.130 |
Why?
| | Menstrual Cycle | 3 | 2011 | 119 | 0.130 |
Why?
| | Breast Feeding | 1 | 2018 | 387 | 0.130 |
Why?
| | Growth Hormone-Secreting Pituitary Adenoma | 1 | 2014 | 11 | 0.130 |
Why?
| | Acromegaly | 1 | 2014 | 15 | 0.130 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2015 | 127 | 0.130 |
Why?
| | Decision Support Systems, Clinical | 1 | 2017 | 177 | 0.130 |
Why?
| | Dementia | 2 | 2008 | 222 | 0.130 |
Why?
| | Biomarkers | 4 | 2021 | 3652 | 0.130 |
Why?
| | Gonadotropin-Releasing Hormone | 4 | 2020 | 209 | 0.120 |
Why?
| | Pituitary-Adrenal System | 3 | 2013 | 184 | 0.120 |
Why?
| | Brain Ischemia | 1 | 2017 | 300 | 0.120 |
Why?
| | Antibody Formation | 2 | 2022 | 277 | 0.120 |
Why?
| | Arthritis, Rheumatoid | 1 | 2022 | 957 | 0.120 |
Why?
| | Analysis of Variance | 5 | 2009 | 1383 | 0.120 |
Why?
| | Interviews as Topic | 3 | 2010 | 604 | 0.120 |
Why?
| | Drug Administration Schedule | 4 | 2010 | 770 | 0.120 |
Why?
| | Secretory Rate | 1 | 2013 | 18 | 0.120 |
Why?
| | Health Care Costs | 1 | 2017 | 411 | 0.120 |
Why?
| | Neurosurgical Procedures | 1 | 2014 | 165 | 0.110 |
Why?
| | Electronics | 1 | 2013 | 76 | 0.110 |
Why?
| | Immunoenzyme Techniques | 1 | 2013 | 207 | 0.110 |
Why?
| | Adenoma | 1 | 2014 | 190 | 0.110 |
Why?
| | Arrhythmias, Cardiac | 1 | 2015 | 324 | 0.110 |
Why?
| | Education, Medical, Graduate | 1 | 2016 | 424 | 0.110 |
Why?
| | Medical Records | 1 | 2013 | 181 | 0.110 |
Why?
| | Ventricular Function, Left | 1 | 2015 | 499 | 0.110 |
Why?
| | Wakefulness | 1 | 2013 | 156 | 0.110 |
Why?
| | Age Factors | 8 | 2018 | 3173 | 0.110 |
Why?
| | Severity of Illness Index | 5 | 2022 | 2876 | 0.110 |
Why?
| | Urban Health | 2 | 2009 | 92 | 0.110 |
Why?
| | Antibodies, Monoclonal | 3 | 2022 | 1289 | 0.110 |
Why?
| | Insulin | 1 | 2022 | 2156 | 0.110 |
Why?
| | Dietary Supplements | 1 | 2015 | 465 | 0.110 |
Why?
| | Memory | 3 | 2008 | 271 | 0.100 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2015 | 398 | 0.100 |
Why?
| | Follow-Up Studies | 5 | 2017 | 4883 | 0.100 |
Why?
| | Progestins | 1 | 2011 | 78 | 0.100 |
Why?
| | Statistics as Topic | 2 | 2009 | 328 | 0.100 |
Why?
| | Amenorrhea | 1 | 2011 | 30 | 0.100 |
Why?
| | Dopamine Agonists | 2 | 2008 | 31 | 0.100 |
Why?
| | Cognition | 3 | 2008 | 1083 | 0.100 |
Why?
| | Equipment Design | 1 | 2013 | 529 | 0.100 |
Why?
| | Contraceptives, Oral, Hormonal | 2 | 2007 | 23 | 0.100 |
Why?
| | Birth Certificates | 1 | 2010 | 8 | 0.100 |
Why?
| | Birth Rate | 2 | 2020 | 19 | 0.100 |
Why?
| | Estrone | 1 | 2010 | 34 | 0.100 |
Why?
| | Automobile Driving | 2 | 2010 | 131 | 0.100 |
Why?
| | Dihydrotestosterone | 1 | 2010 | 41 | 0.100 |
Why?
| | Cytokines | 2 | 2015 | 1904 | 0.100 |
Why?
| | Live Birth | 2 | 2020 | 46 | 0.100 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2010 | 11 | 0.100 |
Why?
| | Risk Assessment | 2 | 2017 | 3248 | 0.100 |
Why?
| | Pregnancy Rate | 2 | 2020 | 55 | 0.100 |
Why?
| | Diet | 1 | 2018 | 1164 | 0.100 |
Why?
| | Geographic Information Systems | 2 | 2010 | 42 | 0.100 |
Why?
| | Abortion, Induced | 2 | 2008 | 67 | 0.090 |
Why?
| | Fertilization in Vitro | 2 | 2020 | 73 | 0.090 |
Why?
| | Thyroxine | 2 | 2007 | 64 | 0.090 |
Why?
| | United States | 6 | 2020 | 13209 | 0.090 |
Why?
| | Cities | 1 | 2010 | 98 | 0.090 |
Why?
| | Myocardial Infarction | 1 | 2017 | 1142 | 0.090 |
Why?
| | Sex Factors | 5 | 2018 | 1898 | 0.090 |
Why?
| | Personality | 1 | 2011 | 117 | 0.090 |
Why?
| | Registries | 1 | 2017 | 1956 | 0.090 |
Why?
| | Electrical Equipment and Supplies | 1 | 2009 | 8 | 0.090 |
Why?
| | Rehabilitation Centers | 1 | 2009 | 37 | 0.090 |
Why?
| | Independent Living | 1 | 2010 | 86 | 0.090 |
Why?
| | Telecommunications | 1 | 2009 | 20 | 0.090 |
Why?
| | Treatment Outcome | 7 | 2015 | 9654 | 0.090 |
Why?
| | Pattern Recognition, Automated | 1 | 2009 | 84 | 0.090 |
Why?
| | Mortality | 1 | 2011 | 325 | 0.090 |
Why?
| | Progesterone | 3 | 2015 | 248 | 0.080 |
Why?
| | Rural Health | 1 | 2009 | 83 | 0.080 |
Why?
| | Postmenopause | 1 | 2010 | 323 | 0.080 |
Why?
| | Drug Interactions | 2 | 2007 | 368 | 0.080 |
Why?
| | Child, Preschool | 4 | 2018 | 9776 | 0.080 |
Why?
| | Thyrotoxicosis | 1 | 2008 | 7 | 0.080 |
Why?
| | Foot | 1 | 2009 | 106 | 0.080 |
Why?
| | Exercise | 3 | 2010 | 1866 | 0.080 |
Why?
| | Vaccinia | 1 | 2007 | 20 | 0.080 |
Why?
| | Povidone-Iodine | 1 | 2007 | 11 | 0.080 |
Why?
| | Life Change Events | 1 | 2009 | 142 | 0.080 |
Why?
| | Monitoring, Ambulatory | 1 | 2009 | 86 | 0.080 |
Why?
| | Ointments | 1 | 2007 | 27 | 0.080 |
Why?
| | Smallpox Vaccine | 1 | 2007 | 23 | 0.080 |
Why?
| | Logistic Models | 2 | 2010 | 2037 | 0.080 |
Why?
| | Vaccinia virus | 1 | 2007 | 41 | 0.080 |
Why?
| | Pregnancy, Unplanned | 1 | 2008 | 40 | 0.080 |
Why?
| | CD4 Lymphocyte Count | 2 | 2020 | 271 | 0.080 |
Why?
| | Parkinsonian Disorders | 1 | 2007 | 30 | 0.080 |
Why?
| | Disease Progression | 3 | 2015 | 2582 | 0.080 |
Why?
| | Counseling | 1 | 2010 | 363 | 0.080 |
Why?
| | Dyskinesia, Drug-Induced | 1 | 2007 | 11 | 0.080 |
Why?
| | Atrophy | 1 | 2007 | 158 | 0.080 |
Why?
| | Time Perception | 1 | 2007 | 23 | 0.080 |
Why?
| | Antigens, Bacterial | 1 | 2007 | 125 | 0.080 |
Why?
| | Population Surveillance | 1 | 2010 | 439 | 0.080 |
Why?
| | Albumins | 1 | 2007 | 96 | 0.080 |
Why?
| | Awareness | 1 | 2007 | 96 | 0.080 |
Why?
| | Antibodies, Bacterial | 1 | 2007 | 138 | 0.080 |
Why?
| | Antigens, Viral | 1 | 2007 | 185 | 0.070 |
Why?
| | Wounds, Gunshot | 1 | 2009 | 170 | 0.070 |
Why?
| | Tremor | 1 | 2007 | 48 | 0.070 |
Why?
| | Suicide, Attempted | 1 | 2009 | 318 | 0.070 |
Why?
| | Movement | 1 | 2009 | 257 | 0.070 |
Why?
| | Blood-Brain Barrier | 1 | 2007 | 108 | 0.070 |
Why?
| | Internship and Residency | 1 | 2016 | 1045 | 0.070 |
Why?
| | Emergency Service, Hospital | 1 | 2017 | 1841 | 0.070 |
Why?
| | Infant | 3 | 2010 | 8440 | 0.070 |
Why?
| | Cost-Benefit Analysis | 1 | 2009 | 560 | 0.070 |
Why?
| | Paroxetine | 1 | 2005 | 7 | 0.070 |
Why?
| | Treatment Failure | 2 | 2022 | 343 | 0.070 |
Why?
| | Animals | 6 | 2023 | 34134 | 0.070 |
Why?
| | Health Policy | 1 | 2008 | 356 | 0.060 |
Why?
| | Neurologic Examination | 2 | 2008 | 128 | 0.060 |
Why?
| | Attitude to Health | 1 | 2008 | 417 | 0.060 |
Why?
| | Administration, Oral | 1 | 2007 | 793 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1871 | 0.060 |
Why?
| | Health Promotion | 1 | 2010 | 711 | 0.060 |
Why?
| | Child | 5 | 2018 | 19282 | 0.060 |
Why?
| | Patient Compliance | 1 | 2008 | 569 | 0.060 |
Why?
| | Likelihood Functions | 2 | 2017 | 144 | 0.060 |
Why?
| | Sexual Behavior | 1 | 2008 | 483 | 0.060 |
Why?
| | Family | 1 | 2008 | 596 | 0.060 |
Why?
| | Follicle Stimulating Hormone, Human | 1 | 2023 | 11 | 0.060 |
Why?
| | Neurites | 1 | 2023 | 43 | 0.060 |
Why?
| | Diffusion Tensor Imaging | 1 | 2023 | 87 | 0.060 |
Why?
| | Linear Models | 2 | 2020 | 886 | 0.060 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2023 | 91 | 0.060 |
Why?
| | Sex Characteristics | 1 | 2007 | 700 | 0.060 |
Why?
| | Physical Fitness | 1 | 2004 | 189 | 0.060 |
Why?
| | Temporomandibular Joint Dysfunction Syndrome | 1 | 2002 | 4 | 0.060 |
Why?
| | Vaccines | 1 | 2007 | 371 | 0.060 |
Why?
| | Ritonavir | 1 | 2023 | 72 | 0.060 |
Why?
| | Facial Pain | 1 | 2002 | 12 | 0.060 |
Why?
| | Emotions | 1 | 2007 | 530 | 0.060 |
Why?
| | B-Lymphocytes | 1 | 2007 | 793 | 0.050 |
Why?
| | Motor Activity | 1 | 2007 | 705 | 0.050 |
Why?
| | Practice Patterns, Physicians' | 1 | 2011 | 1247 | 0.050 |
Why?
| | Acids | 1 | 2002 | 21 | 0.050 |
Why?
| | Administration, Cutaneous | 2 | 2015 | 128 | 0.050 |
Why?
| | Physical Examination | 2 | 2018 | 255 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2011 | 1491 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 3 | 2008 | 3240 | 0.050 |
Why?
| | Ovarian Follicle | 1 | 2002 | 60 | 0.050 |
Why?
| | Odds Ratio | 3 | 2010 | 1052 | 0.050 |
Why?
| | Patient Acceptance of Health Care | 1 | 2007 | 693 | 0.050 |
Why?
| | Herpesvirus 4, Human | 1 | 2022 | 136 | 0.050 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2022 | 87 | 0.050 |
Why?
| | Neuroimaging | 1 | 2023 | 255 | 0.050 |
Why?
| | Rheumatoid Factor | 1 | 2022 | 152 | 0.050 |
Why?
| | Puberty | 1 | 2002 | 147 | 0.050 |
Why?
| | Oocyte Retrieval | 1 | 2020 | 12 | 0.050 |
Why?
| | Immunoglobulin A | 1 | 2022 | 176 | 0.050 |
Why?
| | Pregnancy, Multiple | 1 | 2020 | 19 | 0.050 |
Why?
| | Breast Neoplasms | 2 | 2011 | 1970 | 0.050 |
Why?
| | Immunoglobulin M | 1 | 2022 | 249 | 0.050 |
Why?
| | Embryo Transfer | 1 | 2020 | 30 | 0.050 |
Why?
| | Leptin | 1 | 2002 | 232 | 0.050 |
Why?
| | Blastocyst | 1 | 2020 | 48 | 0.050 |
Why?
| | Fasting | 1 | 2002 | 279 | 0.050 |
Why?
| | Prostaglandins | 1 | 2000 | 84 | 0.050 |
Why?
| | Radionuclide Imaging | 1 | 2019 | 141 | 0.050 |
Why?
| | Case-Control Studies | 4 | 2009 | 3314 | 0.050 |
Why?
| | Depression | 1 | 2008 | 1201 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2009 | 2046 | 0.040 |
Why?
| | Endotoxins | 1 | 2000 | 239 | 0.040 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2007 | 1225 | 0.040 |
Why?
| | Decompression, Surgical | 1 | 1999 | 101 | 0.040 |
Why?
| | Immunization, Secondary | 1 | 2018 | 86 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 1965 | 0.040 |
Why?
| | Denmark | 1 | 2017 | 40 | 0.040 |
Why?
| | Depressive Disorder, Major | 1 | 2001 | 317 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2022 | 792 | 0.040 |
Why?
| | Controlled Before-After Studies | 1 | 2017 | 15 | 0.040 |
Why?
| | Electromyography | 1 | 1999 | 345 | 0.040 |
Why?
| | Genetic Testing | 1 | 2020 | 409 | 0.040 |
Why?
| | Psychological Tests | 1 | 2018 | 132 | 0.040 |
Why?
| | Viruses | 1 | 2018 | 96 | 0.040 |
Why?
| | Milk | 1 | 2018 | 128 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2008 | 337 | 0.040 |
Why?
| | Depressive Disorder | 1 | 2000 | 367 | 0.040 |
Why?
| | Biostatistics | 1 | 2017 | 19 | 0.040 |
Why?
| | Incidence | 2 | 2017 | 2520 | 0.040 |
Why?
| | Signal-To-Noise Ratio | 1 | 2017 | 60 | 0.040 |
Why?
| | Antiviral Agents | 1 | 2023 | 673 | 0.040 |
Why?
| | Thyrotropin | 2 | 2007 | 109 | 0.040 |
Why?
| | Neoplasms | 1 | 2011 | 2241 | 0.040 |
Why?
| | Drug Combinations | 2 | 2011 | 301 | 0.040 |
Why?
| | Health Surveys | 2 | 2009 | 478 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2018 | 242 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2000 | 861 | 0.040 |
Why?
| | Survival Analysis | 1 | 2019 | 1356 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 853 | 0.040 |
Why?
| | Escherichia coli | 1 | 2000 | 791 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2015 | 62 | 0.030 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 201 | 0.030 |
Why?
| | Fatty Liver | 1 | 2018 | 250 | 0.030 |
Why?
| | Systole | 1 | 2015 | 179 | 0.030 |
Why?
| | Drug Users | 1 | 2015 | 40 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 1999 | 1425 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 246 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2015 | 1176 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 781 | 0.030 |
Why?
| | Electric Countershock | 1 | 2015 | 130 | 0.030 |
Why?
| | Phospholipids | 1 | 2015 | 200 | 0.030 |
Why?
| | Substance Abuse, Intravenous | 1 | 2015 | 94 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2015 | 564 | 0.030 |
Why?
| | Risk | 1 | 2017 | 925 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 5054 | 0.030 |
Why?
| | Psychometrics | 1 | 2018 | 700 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2018 | 3800 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2018 | 632 | 0.030 |
Why?
| | Phenotype | 1 | 2022 | 3078 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 678 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2015 | 382 | 0.030 |
Why?
| | Death, Sudden, Cardiac | 1 | 2015 | 225 | 0.030 |
Why?
| | Follicular Phase | 2 | 2004 | 44 | 0.030 |
Why?
| | Colorado | 1 | 2023 | 4344 | 0.030 |
Why?
| | Estrogens | 1 | 2015 | 326 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2015 | 901 | 0.030 |
Why?
| | Fatty Acids | 1 | 2015 | 406 | 0.030 |
Why?
| | Neuropsychological Tests | 2 | 2008 | 1140 | 0.030 |
Why?
| | Feeding Behavior | 1 | 2018 | 625 | 0.030 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 486 | 0.030 |
Why?
| | Mothers | 1 | 2018 | 707 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2015 | 1574 | 0.030 |
Why?
| | Prognosis | 1 | 1999 | 3603 | 0.020 |
Why?
| | Defibrillators, Implantable | 1 | 2015 | 411 | 0.020 |
Why?
| | Abbreviated Injury Scale | 1 | 2010 | 21 | 0.020 |
Why?
| | Electronic Health Records | 1 | 2017 | 821 | 0.020 |
Why?
| | Nasal Polyps | 1 | 2010 | 44 | 0.020 |
Why?
| | Life Expectancy | 1 | 2010 | 59 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 5336 | 0.020 |
Why?
| | Trauma Severity Indices | 1 | 2010 | 132 | 0.020 |
Why?
| | Heart Transplantation | 1 | 2015 | 759 | 0.020 |
Why?
| | Heart-Assist Devices | 1 | 2015 | 486 | 0.020 |
Why?
| | Amides | 1 | 2010 | 89 | 0.020 |
Why?
| | Glasgow Coma Scale | 1 | 2010 | 159 | 0.020 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2015 | 987 | 0.020 |
Why?
| | Income | 1 | 2010 | 178 | 0.020 |
Why?
| | Benzodioxoles | 1 | 2010 | 84 | 0.020 |
Why?
| | Reference Values | 1 | 2010 | 804 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2010 | 348 | 0.020 |
Why?
| | Norgestrel | 1 | 1988 | 2 | 0.020 |
Why?
| | Obstetrics | 1 | 2011 | 168 | 0.020 |
Why?
| | Medroxyprogesterone | 1 | 1988 | 10 | 0.020 |
Why?
| | Family Characteristics | 1 | 2010 | 162 | 0.020 |
Why?
| | Administration, Intravaginal | 1 | 1988 | 44 | 0.020 |
Why?
| | Medroxyprogesterone Acetate | 1 | 1988 | 30 | 0.020 |
Why?
| | Poverty Areas | 1 | 2008 | 35 | 0.020 |
Why?
| | Thyroid Function Tests | 1 | 2008 | 11 | 0.020 |
Why?
| | Sheep | 2 | 2002 | 759 | 0.020 |
Why?
| | Receptors, Dopamine | 1 | 2008 | 21 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2009 | 275 | 0.020 |
Why?
| | Employment | 1 | 2010 | 151 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2010 | 415 | 0.020 |
Why?
| | Parity | 1 | 1988 | 105 | 0.020 |
Why?
| | Intelligence Tests | 1 | 2008 | 68 | 0.020 |
Why?
| | Smallpox | 1 | 2007 | 7 | 0.020 |
Why?
| | Commerce | 1 | 2008 | 56 | 0.020 |
Why?
| | Personal Satisfaction | 1 | 2010 | 190 | 0.020 |
Why?
| | Diphtheria | 1 | 2007 | 20 | 0.020 |
Why?
| | Gynecology | 1 | 2011 | 190 | 0.020 |
Why?
| | Tetanus | 1 | 2007 | 26 | 0.020 |
Why?
| | Galvanic Skin Response | 1 | 2007 | 27 | 0.020 |
Why?
| | Cause of Death | 1 | 2010 | 400 | 0.020 |
Why?
| | Virus Shedding | 1 | 2007 | 50 | 0.020 |
Why?
| | Half-Life | 1 | 2007 | 150 | 0.020 |
Why?
| | Lymphocyte Count | 1 | 2007 | 135 | 0.020 |
Why?
| | Contraindications | 1 | 2007 | 100 | 0.020 |
Why?
| | Plasma Cells | 1 | 2007 | 62 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 466 | 0.020 |
Why?
| | Educational Status | 1 | 2010 | 445 | 0.020 |
Why?
| | Surveys and Questionnaires | 2 | 2011 | 4922 | 0.020 |
Why?
| | Seroepidemiologic Studies | 1 | 2007 | 156 | 0.020 |
Why?
| | Triiodothyronine | 1 | 2007 | 43 | 0.020 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2007 | 48 | 0.020 |
Why?
| | Apolipoproteins E | 1 | 2007 | 93 | 0.020 |
Why?
| | Thyroid Hormones | 1 | 2007 | 56 | 0.020 |
Why?
| | Photic Stimulation | 1 | 2007 | 220 | 0.020 |
Why?
| | Thyroid Gland | 1 | 2007 | 82 | 0.020 |
Why?
| | Family Practice | 1 | 2011 | 486 | 0.020 |
Why?
| | Cerebrovascular Disorders | 1 | 2007 | 100 | 0.020 |
Why?
| | Research | 1 | 2010 | 446 | 0.020 |
Why?
| | Age of Onset | 1 | 2008 | 479 | 0.020 |
Why?
| | Neural Inhibition | 1 | 2007 | 168 | 0.020 |
Why?
| | Safety | 1 | 2008 | 313 | 0.020 |
Why?
| | Motor Skills | 1 | 2007 | 95 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2010 | 618 | 0.020 |
Why?
| | Mental Recall | 1 | 2007 | 201 | 0.020 |
Why?
| | Dopamine Agents | 1 | 2005 | 15 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2008 | 574 | 0.020 |
Why?
| | Virus Diseases | 1 | 2007 | 201 | 0.020 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2007 | 366 | 0.020 |
Why?
| | Inpatients | 1 | 2009 | 390 | 0.020 |
Why?
| | Vestibular Diseases | 1 | 2005 | 23 | 0.020 |
Why?
| | Dizziness | 1 | 2005 | 73 | 0.020 |
Why?
| | Presynaptic Terminals | 1 | 2005 | 59 | 0.020 |
Why?
| | Down-Regulation | 1 | 2007 | 639 | 0.020 |
Why?
| | Self Efficacy | 1 | 2008 | 363 | 0.020 |
Why?
| | Gait Disorders, Neurologic | 1 | 2005 | 41 | 0.020 |
Why?
| | Length of Stay | 1 | 2009 | 1056 | 0.020 |
Why?
| | Comorbidity | 1 | 2010 | 1633 | 0.020 |
Why?
| | Memory, Short-Term | 1 | 2007 | 265 | 0.020 |
Why?
| | Diet Records | 1 | 2004 | 81 | 0.020 |
Why?
| | Menarche | 1 | 2004 | 50 | 0.020 |
Why?
| | Research Design | 1 | 2010 | 1003 | 0.020 |
Why?
| | Chronic Disease | 1 | 2010 | 1655 | 0.020 |
Why?
| | Overweight | 1 | 2008 | 544 | 0.010 |
Why?
| | Caregivers | 1 | 2010 | 717 | 0.010 |
Why?
| | Serotonin | 1 | 2005 | 330 | 0.010 |
Why?
| | Accidental Falls | 1 | 2005 | 164 | 0.010 |
Why?
| | Skin | 1 | 2007 | 703 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2008 | 1254 | 0.010 |
Why?
| | Dopamine | 1 | 2005 | 284 | 0.010 |
Why?
| | Stress, Psychological | 1 | 2011 | 1067 | 0.010 |
Why?
| | Follicular Fluid | 1 | 2002 | 8 | 0.010 |
Why?
| | Contraceptives, Oral | 1 | 2002 | 27 | 0.010 |
Why?
| | Neuraminidase | 1 | 2002 | 27 | 0.010 |
Why?
| | Adrenal Cortex | 1 | 2002 | 37 | 0.010 |
Why?
| | Hormone Antagonists | 1 | 2002 | 43 | 0.010 |
Why?
| | Dipeptides | 1 | 2002 | 50 | 0.010 |
Why?
| | Heart Failure | 1 | 2015 | 2142 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 2002 | 190 | 0.010 |
Why?
| | Thinness | 1 | 2002 | 96 | 0.010 |
Why?
| | Postprandial Period | 1 | 2002 | 101 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2004 | 646 | 0.010 |
Why?
| | Pituitary Gland | 1 | 2002 | 161 | 0.010 |
Why?
| | Periodicity | 1 | 2000 | 60 | 0.010 |
Why?
| | Luteal Phase | 1 | 2000 | 47 | 0.010 |
Why?
| | HIV Infections | 1 | 2015 | 2506 | 0.010 |
Why?
| | Energy Intake | 1 | 2004 | 494 | 0.010 |
Why?
| | Area Under Curve | 1 | 2001 | 308 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2002 | 347 | 0.010 |
Why?
| | Prostaglandin Antagonists | 1 | 2000 | 3 | 0.010 |
Why?
| | Flurbiprofen | 1 | 2000 | 3 | 0.010 |
Why?
| | Depression, Chemical | 1 | 2000 | 28 | 0.010 |
Why?
| | Pain Measurement | 1 | 2002 | 484 | 0.010 |
Why?
| | Vaccination | 1 | 2007 | 1218 | 0.010 |
Why?
| | Fever | 1 | 2000 | 291 | 0.010 |
Why?
| | Hypertension | 1 | 2007 | 1241 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2007 | 2377 | 0.010 |
Why?
| | Sleep | 1 | 2002 | 794 | 0.010 |
Why?
| | Mice | 1 | 2007 | 15621 | 0.010 |
Why?
|
|
Carlson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|